Looking to expand your partner network with leading companies like MolMed? Consider joining Inpart's global network for free.
Interview 18 Apr 2018
What Lies Ahead for European Cell and Gene Therapies?
Cell and gene therapies have recently made big advances in providing effective treatments for a variety of conditions, from cancers to rare diseases. Nonetheless, there are still significant challenges ahead before the technologies can become a viable treatment option for most patients. What if you could treat a disease on the level of tissue and […]
